Skip to content
healthcare.dev

Eslicarbazepine Acetate

NDC 43598-687, Eslicarbazepine Acetate, tablet, from Dr.Reddys Laboratories Inc.

Product NDC
43598-687
Status
Listed
Labeler
Dr.Reddys Laboratories Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211238
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-687 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE800 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
43598-687-304359806873030 TABLET in 1 BOTTLE (43598-687-30)
43598-687-904359806879090 TABLET in 1 BOTTLE (43598-687-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/190fccbc-da3f-b175-ac02-f2c4307a15c3
  • NADAC price for package 43598068730

    GET /v1/drugs/nadac/43598068730

Use it

Look up 43598-687 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-687 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-687. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.